EUVIMEDEUVIMED entdecken
Crossref

FGF21 protects against ischaemia reperfusion injury in normal and fatty livers

Yong Ma iD, Garima Singhal, Suzanne S Chan, Chaoqun Wang, Hongjun Yu, Bing Yin, Jing Pang, Grace Malvar, Imad Nasser, Marie L Mather, Eleftheria Maratos-Flier

Liver International · 2024

DOI: 10.1111/liv.15911 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Liver International, 2024. Verfasst von Yong Ma und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Fibroblast Growth Factors, Reperfusion Injury, Mice, Knockout, Liver. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: National Natural Scientific Foundation of China 81470876, 82370643 (YM), Natural Science Foundation of Heilongjiang Province of China LC2018037 (YM), National Institutes of Health Grant R01 DK028082-035 (EMF, JSF).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Liver ischaemia/reperfusion (I/R) injury, which is an inevitable clinical problem of liver resection, liver transplantation and haemorrhagic shock. Fibroblast growth factor 21 (FGF21) was intimately coupled with multiple metabolic processes and proved to protect against apoptosis and inflammatory response in hepatocytes during hepatic I/R injury. However, the regulatory mechanisms of FGF21 in hepatic I/R injury remains unknown. Therefore, we hypothesize that FGF21 protects hepatic tissues from I/R injury.

Methods

Blood samples were available from haemangiomas patients undergoing hepatectomy and murine liver I/R model and used to further evaluate the serum levels of FGF21 both in humans and mice. We further explored the regulatory mechanisms of FGF21 in murine liver I/R model by using FGF21‐knockout mice (FGF21‐KO mice) and FGF21‐overexpression transgenic mice (FGF21‐OE mice) fed a high‐fat or ketogenic diet.

Results

Our results show that the circulating levels of FGF21 were robustly decreased after liver I/R in both humans and mice. Silencing FGF21 expression with FGF21‐KO mice aggravates liver injury at 6 h after 75 min of partial liver ischaemia, while FGF21‐OE mice display alleviated hepatic I/R injury and inflammatory response. Compared with chow diet mice, exogenous FGF21 decreases the levels of aminotransferase, histological changes, apoptosis and inflammatory response in hepatic I/R injury treatment mice with a high‐fat diet. Meanwhile, ketogenic diet mice are not sensitive to hepatic I/R injury.

Conclusions

The circulating contents of FGF21 are decreased during liver warm I/R injury and exogenous FGF21 exerts hepatoprotective effects on hepatic I/R injury. Thus, FGF21 regulates hepatic I/R injury and may be a key therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fibroblast Growth FactorsReperfusion InjuryMice, KnockoutLiverDisease Models, AnimalAnimalsHumansMiceMaleMice, Inbred C57BLApoptosisFatty LiverHepatocytesMice, TransgenicFemaleHepatectomy

Stichwörter der Autor:innen

fibroblast growth factor 21inflammationinjuryischaemia/reperfusionliver

Substanzen

Fibroblast Growth Factorsfibroblast growth factor 21FGF21 protein, human

Autor:innen und Institutionen

  • Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
  • Key Laboratory of Hepatosplenic Surgery, Ministry of Education, Department of Minimal Invasive Hepatic Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
  • Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.

ORCID-Profile: Yong Ma

Förderung

  • National Natural Scientific Foundation of China 81470876, 82370643 (YM)
  • Natural Science Foundation of Heilongjiang Province of China LC2018037 (YM)
  • National Institutes of Health Grant R01 DK028082-035 (EMF, JSF)
  • NIDDK NIH HHS

Zitieren

APA

Ma, Y., Singhal, G., Chan, S. S., Wang, C., Yu, H., Yin, B., Pang, J., Malvar, G., Nasser, I., Mather, M. L., & Maratos-Flier, E. (2024). FGF21 protects against ischaemia reperfusion injury in normal and fatty livers. Liver International. https://doi.org/10.1111/liv.15911

Vancouver

Ma Y, Singhal G, Chan SS, Wang C, Yu H, Yin B, et al. FGF21 protects against ischaemia reperfusion injury in normal and fatty livers. Liver International. 2024. doi:10.1111/liv.15911

BibTeX
@article{Ma2024,
  author = {Ma, Yong and Singhal, Garima and Chan, Suzanne S and Wang, Chaoqun and Yu, Hongjun and Yin, Bing and Pang, Jing and Malvar, Grace and Nasser, Imad and Mather, Marie L and Maratos-Flier, Eleftheria},
  title = {FGF21 protects against ischaemia reperfusion injury in normal and fatty livers},
  journal = {Liver International},
  year = {2024},
  doi = {10.1111/liv.15911}
}
Kostenlos starten →